Michael Stowasser

20.1k total citations · 5 hit papers
224 papers, 11.9k citations indexed

About

Michael Stowasser is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Michael Stowasser has authored 224 papers receiving a total of 11.9k indexed citations (citations by other indexed papers that have themselves been cited), including 173 papers in Endocrinology, Diabetes and Metabolism, 129 papers in Surgery and 61 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Michael Stowasser's work include Hormonal Regulation and Hypertension (171 papers), Adrenal and Paraganglionic Tumors (102 papers) and Adrenal Hormones and Disorders (55 papers). Michael Stowasser is often cited by papers focused on Hormonal Regulation and Hypertension (171 papers), Adrenal and Paraganglionic Tumors (102 papers) and Adrenal Hormones and Disorders (55 papers). Michael Stowasser collaborates with scholars based in Australia, United States and Italy. Michael Stowasser's co-authors include Richard D. Gordon, William F. Young, Robert M. Carey, Franco Mantero, John W. Funder, Martín Reincke, Terry J. Tunny, M. Hassan Murad, Carlos Fardella and Hirotaka Shibata and has published in prestigious journals such as The Lancet, Circulation and Journal of Clinical Oncology.

In The Last Decade

Michael Stowasser

221 papers receiving 11.7k citations

Hit Papers

The Management of Primary Aldosteronis... 2004 2026 2011 2018 2016 2008 2004 2021 2025 500 1000 1.5k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Stowasser Australia 56 9.6k 7.9k 3.0k 1.5k 814 224 11.9k
Paolo Mulatero Italy 47 7.7k 0.8× 6.3k 0.8× 1.8k 0.6× 1.2k 0.8× 460 0.6× 225 9.0k
Vasilios G. Athyros Greece 54 4.2k 0.4× 3.9k 0.5× 2.7k 0.9× 1.3k 0.9× 541 0.7× 285 10.5k
Richard W. Nesto United States 50 4.1k 0.4× 3.2k 0.4× 5.4k 1.8× 2.1k 1.4× 891 1.1× 156 11.2k
Björn Dahlöf Sweden 40 4.3k 0.4× 3.1k 0.4× 8.8k 2.9× 611 0.4× 650 0.8× 104 12.0k
Morris J. Brown United Kingdom 49 4.2k 0.4× 2.2k 0.3× 5.8k 1.9× 1.8k 1.2× 661 0.8× 198 10.1k
Pekka Koskinen Finland 33 3.5k 0.4× 3.6k 0.5× 2.6k 0.9× 877 0.6× 315 0.4× 69 7.6k
David Z.I. Cherney Canada 55 10.7k 1.1× 4.9k 0.6× 2.9k 1.0× 3.6k 2.5× 2.1k 2.5× 331 14.8k
Dorothea Collins United States 26 3.3k 0.3× 3.4k 0.4× 1.5k 0.5× 1.0k 0.7× 788 1.0× 39 6.2k
Adam Whaley‐Connell United States 53 3.6k 0.4× 1.7k 0.2× 3.4k 1.1× 2.2k 1.5× 785 1.0× 217 10.4k
Guntram Schernthaner Austria 60 6.2k 0.6× 2.7k 0.3× 1.4k 0.5× 2.9k 2.0× 525 0.6× 227 11.0k

Countries citing papers authored by Michael Stowasser

Since Specialization
Citations

This map shows the geographic impact of Michael Stowasser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Stowasser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Stowasser more than expected).

Fields of papers citing papers by Michael Stowasser

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Stowasser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Stowasser. The network helps show where Michael Stowasser may publish in the future.

Co-authorship network of co-authors of Michael Stowasser

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Stowasser. A scholar is included among the top collaborators of Michael Stowasser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Stowasser. Michael Stowasser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Adler, Gail K., Michael Stowasser, Ricardo Correa, et al.. (2025). Primary Aldosteronism: An Endocrine Society Clinical Practice Guideline. The Journal of Clinical Endocrinology & Metabolism. 110(9). 2453–2495. 28 indexed citations breakdown →
3.
Gwini, Stella May, Michael Stowasser, Morag J. Young, et al.. (2023). Aldosterone and renin concentrations and blood pressure in young Indigenous and non‐Indigenous adults in the Northern Territory: a cross‐sectional study. The Medical Journal of Australia. 219(6). 263–269. 1 indexed citations
4.
Libianto, Renata, Michael Stowasser, Grant Russell, Peter J. Fuller, & Jun Yang. (2023). Improving Detection Rates for Primary Aldosteronism. Experimental and Clinical Endocrinology & Diabetes. 131(07/08). 402–408. 2 indexed citations
5.
Wu, Aihua, Martin Wolley, Hannah L. Mayr, et al.. (2023). Randomized Trial on the Effect of Oral Potassium Chloride Supplementation on the Thiazide-Sensitive Sodium Chloride Cotransporter in Healthy Adults. Kidney International Reports. 8(6). 1201–1212. 10 indexed citations
6.
Chapman, Niamh, Francine Z. Marques, Dean S. Picone, et al.. (2022). Content and delivery preferences for information to support the management of high blood pressure. Journal of Human Hypertension. 38(1). 70–74. 2 indexed citations
7.
Wu, Aihua, Martin Wolley, Alexandra Matthews, et al.. (2022). In Primary Aldosteronism Acute Potassium Chloride Supplementation Suppresses Abundance and Phosphorylation of the Sodium-Chloride Cotransporter. Kidney360. 3(11). 1909–1923. 3 indexed citations
8.
Wu, Aihua, Martin Wolley, Qi Wu, et al.. (2022). Acute Intravenous NaCl and Volume Expansion Reduces Sodium-Chloride Cotransporter Abundance and Phosphorylation in Urinary Extracellular Vesicles. Kidney360. 3(5). 910–921. 3 indexed citations
9.
Reincke, Martín, Irina Bancos, Paolo Mulatero, et al.. (2021). Diagnosis and treatment of primary aldosteronism. The Lancet Diabetes & Endocrinology. 9(12). 876–892. 170 indexed citations breakdown →
10.
Thuzar, Moe & Michael Stowasser. (2021). The mineralocorticoid receptor—an emerging player in metabolic syndrome?. Journal of Human Hypertension. 35(2). 117–123. 22 indexed citations
11.
Sharman, James E., Faline Howes, Geoffrey A. Head, et al.. (2017). How to measure home blood pressure: Recommendations for healthcare professionals and patients.. PubMed. 45(1). 31–4. 16 indexed citations
12.
Goupil, Rémi, Stelios Fountoulakis, Richard D. Gordon, & Michael Stowasser. (2015). Urinary clonidine suppression testing for the diagnosis of pheochromocytoma. Journal of Hypertension. 33(11). 2286–2293. 1 indexed citations
13.
Stowasser, Michael. (2014). Update in Primary Aldosteronism. The Journal of Clinical Endocrinology & Metabolism. 100(1). 1–10. 56 indexed citations
14.
Funder, John W., Robert M. Carey, Carlos Fardella, et al.. (2008). Case Detection, Diagnosis, and Treatment of Patients with Primary Aldosteronism: An Endocrine Society Clinical Practice Guideline. The Journal of Clinical Endocrinology & Metabolism. 93(9). 3266–3281. 1094 indexed citations breakdown →
15.
Taylor, Paul J., et al.. (2008). Semi-automated analysis of aldosterone by liquid chromatography-tandem mass spectrometry: the new gold standard. Queensland's institutional digital repository (The University of Queensland). 1 indexed citations
16.
Stowasser, Michael & Richard D. Gordon. (2003). Primary aldosteronism—careful investigation is essential and rewarding. Molecular and Cellular Endocrinology. 217(1-2). 33–39. 127 indexed citations
17.
Stowasser, Michael & Richard D. Gordon. (2002). The Aldosterone-Renin Ratio and Primary Aldosteronism. Mayo Clinic Proceedings. 77(2). 202–202. 6 indexed citations
18.
Stowasser, Michael. (2000). Treatment of Familial Hyperaldosteronism Type I: Only Partial Suppression of Adrenocorticotropin Required to Correct Hypertension. The Journal of Clinical Endocrinology & Metabolism. 85(9). 3313–3318. 22 indexed citations
19.
Hawley, Carmel M., et al.. (2000). Alpha-1-antitrypsin phenotypes in patients with renal arterial fibromuscular dysplasia. Journal of Human Hypertension. 14(2). 91–94. 16 indexed citations
20.
Stowasser, Michael, et al.. (1996). PCR‐SSCP ANALYSIS OF THE PROMOTER REGION OF THE RENIN GENE IN PATIENTS WITH ALDOSTERONE‐PRODUCING ADENOMAS. Clinical and Experimental Pharmacology and Physiology. 23(6-7). 584–586. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026